GANX
Gain Therapeutics Inc · NASDAQ NMS - GLOBAL MARKET · Biotechnology
$1.84$-0.02 (-1.08%)
Prices delayed up to 5 minutes
AC Intelligence
AC Intelligence
AC Intelligence for GANX is being prepared.
Key Stats
Key Stats
Open
$1.83
Day High
$1.87
Day Low
$1.72
Prev Close
$1.86
Volume
0
Avg Volume
588.5K
Day Change
$-0.02
Change %
-1.08%
Fundamentals
Fundamentals
P/B
6.67
EPS (TTM)
$-0.65
Market Cap
$79M
52-Wk Range
$1.41 — $4.34
Who Owns This Stock
Who Owns GANX
Other58.7%34 holders
Systematic / Quant21.3%3 holders
Passive / Index14.3%3 holders
Dealer / Bank4.5%7 holders
Tactical / Macro1.1%2 holders
Based on Q4 2025 13F filings + AC behavioral model
49 institutional holders
Top Holders
+712.9%$4540.6B
$3252.2B
+3.8%$2261.1B
$2203.6B
$1584.7B
+125.9%$1195.1B
+8.8%$1010.6B
+45.4%$812.0B
$586.9B
+9.8%$580.8B
$515.2B
$507.3B
$427.3B
+172.4%$392.9B
$343.1B
-70.7%$271.9B
+81.0%$261.0B
$250.7B
$238.3B
$220.2B
Institutional Pressure
Market Regime:Strong Risk-Off (-0.62)SELLINGBUYING
▲
Moderate Selling Pressure
Other(58.7%)
●
—Systematic / Quant(21.3%)
◄◄
De-risking (mechanical)Passive / Index(14.3%)
●
HoldsDealer / Bank(4.5%)
●
FacilitatingTactical / Macro(1.1%)
●
Reducing rapidly14% passive + quality floor won't sell.
Updated daily · Based on Q4 2025 filings + AC behavioral model
Sentiment Signals
Sentiment Signals
→Insider ActivityNo insider transactions in last 90 daysSEC Form 4
↑↑Analyst Consensus10 buy, 1 hold, 0 sellFinnhub
↑↑Inst. Flows60 increased/new, 5 decreased/exited (13F)AC 13F Analysis
Sources: SEC Form 4, Finnhub, AC 13F Analysis
On AcidCapitalist
On AcidCapitalist
No recent mentions of GANX on AcidCapitalist.
Data provided by Finnhub. Prices delayed up to 5 minutes.